Abstract:Introduction Voxel based morphometry (VBM) is a neuroimaging analysis technique that allows investigation of focal differences in brain anatomy, using the statistical approach of so-called statistical parametric mapping [1,2]. Major depressive disorder (MDD) is a common and serious psychiatric illness. In past study, the authors have done many researches to reveal the change in grey matter [3-7]. However, the neurobiology of MDD is largely unknown. The purpose of the present study was to identify brain regions with gray matter volume and density changes with relative large MDD subjects and controls using optimized voxel-based morphometry. Material and Method Fifty one patients experiencing MDD (mean age = 34.6 ± 12.7, twenty five males and twenty eight females) according to the diagnostic criterion of DSM-IV, who had a score of 18 or greater on the 17-item Hamilton Depression Rating Scale (HAMD), and fifty two age and sex matched normal controls (mean age = 37.2 ± 16.1, twenty three males and twenty eight females) were recruited. MR scanning was carried out on a 3.0 TMR scanner (EXCITE, GE Signa, Milwaukee, USA). High resolution 3-dimensional T1-weighted (T1W) images were acquired employing a spoiled gradient recalled (SPGR) sequence with TR/TE = 8.5/3.4 ms, FA = 120, 156 axial slices with thickness = 1 mm, axial FOV 24 × 24 cm and data matrix = 256 × 256. Optimized voxel-based morphometry [2] was conducted using Statistical Parametric Mapping–2 (SPM2) (Welcome Department of Imaging Neuroscience, London [http://www.fil.ion.ucl.ac.uk/spm]). The voxel-based morphometry–2 toolbox, which implements the optimized voxel-based morphometry approach [2], was used for data preprocessing. Voxel-by-voxel-based comparisons of gray matter density and volume were performed between groups using two-sample t tests. The correlation between the regional gray matter changes and clinical symptom severity was examined. A corrected p value of less than 0.001 was deemed to be significant. Results Patients with MDD exhibited higher grey matter volume than normal controls in multiple brain regions including bilateral thalamus, left and right superior parietal lobule, right frontal lobe (Table 1, Figure 1 A, B and C). MDD patients also showed higher grey matter density than normal controls in bilateral thalamus (cluster level p < 0.001, corrected) (Table 1, Figure 1 D). No significant correlation between regional gray matter changes and HAMD scores was found after controlling for age, years of education and duration of illness.

Longitudinal brain volume changes in major depressive disorder

Alterations of Brainstem Volume in Patients with First-Episode and Recurrent Major Depressive Disorder

Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.

A Voxel-Based Meta-Analysis Comparing Medication-Naive Patients of Major Depression with Treated Longer-Term Ill Cases.

Insular-associated causal network of structural covariance evaluating progressive gray matter changes in major depressive disorder

The Dark and Gloomy Brain: Grey Matter Volume Alterations in Major Depressive Disorder–Fine-Grained Meta-Analyses

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Voxel-based morphometric analysis on the volume of gray matter in bipolar I disorder.

Changes in gray matter volume following electroconvulsive therapy in adolescent depression with suicidal ideation: A longitudinal structural magnetic resonance imaging study

Gray Matter Alterations in Adolescent Major Depressive Disorder and Adolescent Bipolar Disorder.

Abnormal brain gray matter volume in patients with major depressive disorder: Associated with childhood trauma?

Regional gray matter changes in major depressive disorder : an optimized voxel-based morphometry study

Reduced grey matter volume in frontal and temporal areas in depression: contributions from voxel-based morphometry study

Meta‐Analysis of Brain Volumetric Abnormalities in Patients with Remitted Major Depressive Disorder

Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement

Structural alterations as a predictor of depression – a 7-Tesla MRI-based multidimensional approach

Reduced gray matter volume of the hippocampal tail in melancholic depression: evidence from an MRI study

Brain Grey Matter Volume Alterations Associated with Antidepressant Response in Major Depressive Disorder.

Heterogeneous alterations in thalamic subfields in major depression disorder

Gray Matter Volume Changes Following Antipsychotic Therapy in First-Episode Schizophrenia Patients: A Longitudinal Voxel-Based Morphometric Study.

Sex Differences in the Clinical Characteristics and Brain Gray Matter Volume Alterations in Unmedicated Patients with Major Depressive Disorder